Homepage
About Us
About Kybora
Leadership Team
Success Stories
Our Global Presence
Social Responsibility
Services
M&A
Licensing
Fundraising
Strategic Advisory
News Feed
Contact
English
English
中文
Homepage
About Us
About Kybora
Leadership Team
Success Stories
Our Global Presence
Social Responsibility
Services
M&A
Licensing
Fundraising
Strategic Advisory
News Feed
Contact
English
English
中文
KYBORA Successfully Helps STADA License Xlucane to Bausch Health
February 26, 2020
Comments are off for this post.
News
About the author
.
Drcom Content Editor
Recent blog post
.
Key Biopharma Deals of 2024
Posted: 7 hours ago
KYBORA Welcomes Stefan Bluemmers as Managing Director
Posted: 3 days ago
Accelerated Approval (AA) and PRV Grant: Implications of the FDA’s Updated Guidance
Posted: 1 week ago
Empowering Dreams through Foundation Rwanda’s KYBORA Program
Posted: 1 week ago
Navigating the Complexities of Priority Review Vouchers in the Context of Accelerated Approval Withdrawals
Posted: 4 weeks ago
Tags
.
#biopharma Licensing
Announcement
Bausch Health
biopharma
biotechnology
China
Conference
Corporate
globalhealthcare
healthtech
Kybora Team
LIcensing
March 2020
mergersandacquisitions
News
Priority List
Stada license
TYPE & ENTER:
Close
